Novel <i>SFRP2</i> DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI
The relationship between body weight and different cancers is now well-recognized and among such cancers, colorectal cancer (CRC) is reported most frequently. Our group recently published findings, through an epigenome-wide association study, suggesting that body mass index (BMI) could act as a rele...
Main Authors: | Amanda Cabrera-Mulero, Ana B. Crujeiras, Andrea G. Izquierdo, Esperanza Torres, Duncan Ayers, Felipe F. Casanueva, Francisco J. Tinahones, Sonsoles Morcillo, Manuel Macias-Gonzalez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/7/1041 |
Similar Items
-
Impact of Tumor <i>LINE-1</i> Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival
by: Hatim Boughanem, et al.
Published: (2020-11-01) -
Early Determination of the Periodontal Domain by the Wnt-Antagonist Frzb/Sfrp3
by: Thimios A. Mitsiadis, et al.
Published: (2017-11-01) -
Association between the <i>APOA2</i> rs3813627 Single Nucleotide Polymorphism and HDL and APOA1 Levels Through BMI
by: Hatim Boughanem, et al.
Published: (2020-02-01) -
Interaction of Osteoarthritis and BMI on <i>Leptin</i> Promoter Methylation in Taiwanese Adults
by: Tzi-Peng Yang, et al.
Published: (2019-12-01) -
A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
by: Jinhua Wang, et al.
Published: (2019-10-01)